Geographic · Property, plant and equipment

Europe — Property, plant and equipment

Bristol-Myers Squibb Europe — Property, plant and equipment increased by 1.5% to $7.66B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.2%, from $7.21B to $7.66B. Over 5 years (FY 2020 to FY 2025), Europe — Property, plant and equipment shows an upward trend with a 5.1% CAGR.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2025
Last reportedQ1 2026
Rolls up toPP&E (Net)

How to read this metric

An increase suggests capital expansion or infrastructure investment in the region, while a decrease may indicate asset divestiture, depreciation, or a shift toward outsourcing production.

Detailed definition

This metric represents the net book value of tangible assets, including manufacturing facilities, laboratories, and admi...

Peer comparison

Peers in the pharmaceutical industry typically report regional property, plant, and equipment values to demonstrate their global manufacturing footprint and supply chain resilience.

Metric ID: bmy_segment_europe_property_plant_and_equipment

Historical Data

21 periods
 Q2 '21Q3 '21Q4 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$5.80B$5.87B$6.05B$1.18B$6.05B$5.97B$6.04B$6.26B$6.28B$6.36B$6.48B$6.65B$6.75B$6.85B$6.90B$7.14B$7.21B$7.37B$7.35B$7.54B$7.66B
QoQ Change+1.3%+3.1%-80.6%+414.2%-1.3%+1.1%+3.6%+0.4%+1.2%+2.0%+2.5%+1.6%+1.4%+0.8%+3.4%+1.1%+2.2%-0.3%+2.6%+1.5%
YoY Change+3.0%+2.8%+3.4%+3.8%+6.4%+7.4%+6.3%+7.5%+7.7%+6.5%+7.4%+6.9%+7.7%+6.5%+5.7%+6.2%
Range$1.18B$7.66B
CAGR+5.7%
Avg YoY Growth+6.0%
Median YoY Growth+6.5%
Current Streak2 quarters growth

Frequently Asked Questions

What is Bristol-Myers Squibb's europe — property, plant and equipment?
Bristol-Myers Squibb (BMY) reported europe — property, plant and equipment of $7.66B in Q1 2026.
How has Bristol-Myers Squibb's europe — property, plant and equipment changed year-over-year?
Bristol-Myers Squibb's europe — property, plant and equipment increased by 6.2% year-over-year, from $7.21B to $7.66B.
What is the long-term trend for Bristol-Myers Squibb's europe — property, plant and equipment?
Over 5 years (2020 to 2025), Bristol-Myers Squibb's europe — property, plant and equipment has grown at a 5.1% compound annual growth rate (CAGR), from $5.89B to $7.54B.
What does europe — property, plant and equipment mean?
The total value of physical assets like factories and offices owned by the company in Europe.